| CAS ID: | 4478-93-7 |
| Molecular Formula: | C6H11NOS2 |
| Molecular Weight: | 177.3 g/mol |
| Monoisotopic Mass: | 177.0282 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | 4-(Methylsulfinyl)Butyl Isothiocyanate |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
| PubMed ID | 26494449 | Target ID | T0543 |
| Uniprot ID | Nuclear factor erythroid 2-related factor 2 | Name | Nuclear factor erythroid 2-related factor 2 |
| Model | mice | Fibrosis Disease | Muscle fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting TGF-β/Smad signaling | ||
Reference Record 2
| PubMed ID | 24707343 | Target ID | |
| Uniprot ID | Name | ||
| Model | mice | Fibrosis Disease | Aortic fibrosis |
| Process I | attenue inflammation | ||
| Process II | cells proliferation,cells apoptosis | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 3
| PubMed ID | 22703534 | Target ID | T0543 |
| Uniprot ID | Nuclear factor erythroid 2-related factor 2 | Name | Nuclear factor erythroid 2-related factor 2 |
| Model | vitro,human,mice | Fibrosis Disease | Idiopathic pulmonary fibrosis |
| Process I | |||
| Process II | fibroblasts proliferation,fibroblasts differentiation,fibroblasts migration | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 4
| PubMed ID | 24967692 | Target ID | |
| Uniprot ID | Name | ||
| Model | mice | Fibrosis Disease | Testicular fibrosis |
| Process I | attenue inflammation | ||
| Process II | cells proliferation,cells apoptosis | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 5
| PubMed ID | 24707343 | Target ID | |
| Uniprot ID | Name | ||
| Model | mice | Fibrosis Disease | Vascular fibrosis |
| Process I | attenue inflammation | ||
| Process II | cells proliferation,cells apoptosis | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT01315665 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | March 15, 2011 | Last Verified | February 15, 2019 |
| Sponsor | University Hospitals Cleveland Medical Center | ||
| PubChem: | 5350 |
| ChEMBL: | CHEMBL48802 |